TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Clinical trial NCT01421511 · COMPLETED
Trial details
- NCT number
- NCT01421511
- Sponsor
- Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-15
- Primary completion
- 2013-01-10
- Enrollment
- 666
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.